Rainier Family Wealth’s Edwards Lifesciences EW Stock Holding History

Rainier Family Wealth’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,581	Closed	-$191K	–	84
2024 Q4	$191K	Buy	+2,581	New	+$181K	0.23%	82

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Rainier Family Wealth's EW Position: Q1 2025 in Review

Rainier Family Wealth sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 2,581 shares — an estimated $191K sold.

Rainier Family Wealth first reported a position in EW in Q4 2024 and held it in 1 quarter. The position peaked at $191K in Q4 2024. 1,207 funds tracked by Wall St. Rank hold EW as of Q1 2025.

Rainier Family Wealth reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
Rainier Family Wealth sold 2,581 Edwards Lifesciences shares in Q1 2025, an estimated $191K.
Rainier Family Wealth first reported a position in Edwards Lifesciences in Q4 2024 and held it in 1 quarter.
Rainier Family Wealth's Edwards Lifesciences position peaked at $191K in Q4 2024.
1,207 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Rainier Family Wealth's 13F filing for Q1 2025, filed 24 Jun 2025.